Literature DB >> 28565749

Main constituents of polyphenol complex from seagrasses of the genus Zostera, their antidiabetic properties and mechanisms of action.

Olga Nikolaevna Styshova1, Alexander Michailovich Popov1,2, Alexander Alekseevish Artyukov1, Anna Anatolievna Klimovich1.   

Abstract

The present review analyzed the recent experimental studies of the alleviating activity of main constituents of the polyphenol complex from seagrasses of the genus Zostera, namely rosmarinic acid, luteolin and its sulfated derivatives, on carbohydrate and lipid metabolism disorders. A number of studies by our group and others, in which various experimental models of diabetes and hyperlipidemia were used, show a therapeutic action of the polyphenol complex and the abovementioned phenolic constituents, when applied separately and in combination. Based on the analysis of the results of these studies, the probable mechanisms of the therapeutic action of these compounds in diabetes and hyperlipidemia were proposed.

Entities:  

Keywords:  diabetes; flavonoids; hyperlipidemia; luteolin; metabolic syndrome; rosmarinic acid

Year:  2017        PMID: 28565749      PMCID: PMC5443317          DOI: 10.3892/etm.2017.4217

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  46 in total

1.  Chemopreventive potential of luteolin during colon carcinogenesis induced by 1,2-dimethylhydrazine.

Authors:  Vaiyapuri Manju; Namasivayam Nalini
Journal:  Ital J Biochem       Date:  2005 Sep-Dec

Review 2.  Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention.

Authors:  Christoph Köhle; Karl Walter Bock
Journal:  Biochem Pharmacol       Date:  2006-04-29       Impact factor: 5.858

3.  Inhibition of xanthine oxidase by flavonoids.

Authors:  A Nagao; M Seki; H Kobayashi
Journal:  Biosci Biotechnol Biochem       Date:  1999-10       Impact factor: 2.043

4.  Rosmarinic acid as a downstream inhibitor of IKK-beta in TNF-alpha-induced upregulation of CCL11 and CCR3.

Authors:  Jongsung Lee; Eunsun Jung; Youngji Kim; Jiyoung Lee; Junho Park; Seongtaek Hong; Chang-Gu Hyun; Deokhoon Park; Yeong Shik Kim
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

5.  Leishmania donovani: intracellular ATP level regulates apoptosis-like death in luteolin induced dyskinetoplastid cells.

Authors:  Nilkantha Sen; Benu Brata Das; Agneyo Ganguly; Bijoylaxhmi Banerjee; Tanusree Sen; Hemanta K Majumder
Journal:  Exp Parasitol       Date:  2006-05-16       Impact factor: 2.011

6.  Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells.

Authors:  Gabriel K Harris; Yong Qian; Stephen S Leonard; Deborah C Sbarra; Xianglin Shi
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

7.  Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages.

Authors:  A Xagorari; A Papapetropoulos; A Mauromatis; M Economou; T Fotsis; C Roussos
Journal:  J Pharmacol Exp Ther       Date:  2001-01       Impact factor: 4.030

8.  Redox-dependent downregulation of Rho by Rac.

Authors:  Anjaruwee S Nimnual; Laura J Taylor; Dafna Bar-Sagi
Journal:  Nat Cell Biol       Date:  2003-03       Impact factor: 28.824

Review 9.  Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.

Authors:  Philippe Gervois; Jean-Charles Fruchart; Bart Staels
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

10.  Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells.

Authors:  Ran-Xin Shi; Choon-Nam Ong; Han-Ming Shen
Journal:  Oncogene       Date:  2004-10-07       Impact factor: 9.867

View more
  2 in total

Review 1.  Bioactive Properties of Marine Phenolics.

Authors:  Raquel Mateos; José Ricardo Pérez-Correa; Herminia Domínguez
Journal:  Mar Drugs       Date:  2020-09-30       Impact factor: 5.118

2.  Comparative Study of the Pharmacological Properties of Luteolin and Its 7,3'-Disulfate.

Authors:  Emma P Kozlovskaya; Aleksandr M Popov; Olga N Styshova; Aleksey I Vakhrushev; Tatyana A Rutckova; Anna B Podvolotskaya; Ludmila A Tekutyeva
Journal:  Mar Drugs       Date:  2022-06-28       Impact factor: 6.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.